2017 Neonatal Pharmacology

PC215 - Closing PDA in Preterm Infants: Whether, When, and How (Rx = .75 hr.)

Apr 6, 2017 2:15pm ‐ Apr 6, 2017 3:00pm


Credits: None available.

Standard: $15.00

Description

Learning Objectives:

  • Describe the evidence supporting early, routine intervention to close the ductus arteriosus in preterm infants
  • Discuss the impact of open-label treatment of control subjects in trials of PDA treatment in preterm infants
  • Know the relationship between postnatal age at treatment and evidence from controlled trials of PDA treatment

Speaker(s):

Credits

  • 0.75 - Pharmacology
  • 1.25 - Physician
  • 1.25 - RN / NP (All RNs/Nurses except CA RNs)
  • 1.25 - CA RN/CA BRN
  • 0.75 - Pharmacist

You must be logged in and own this session in order to post comments.